<%! public String sectionVar = "equity"; public String sectionTitle = "Equity Research"; public String pageVar = "  2007 Reports"; public String pageTitle = "2007 Equity Research"; %> <%@ include file="/includes/header.jsp" %>

Please see our legal disclaimers within this disclosure section on the web site and/or on the last page of each company review or update. Past research reviews should not be relied upon for any purpose. Research reviews speak only as of the date of the review, and at any time thereafter may no longer be factually accurate and may not reflect our analyst's views on any security.

2007 Reports

Nventa Biopharmaceuticals, Corp.
(NVN.TO, TSX)
12.17.07
A Very Promising Therapeutic and Vaccine Candidate for the Treatment of Diseases Caused by the Human Papillomavirus (HPV).

Arbios Systems, Inc.
(NASDAQ: OTC.BB)
12.03.07
A New Tool for Rescuing Patients Who’s Livers Are Failing.

Advanced Research Technologies, Inc.
(ARA.TO: TSX)
11.19.07
Reversing the Trend by Energizing Optix®’s Commercialization Strategy with a Higher Margin Opportunity and Sales Leadership.

Neurobiological Technologies, Inc.
(NTII: NASDAQ)
11.13.07
Injecting Confidence to the Viprinex™ Mission by a Successful $60m Offering; Mountains Do Move.

StatSure Diagnostic Systems, Inc.
(NASDAQ:SSUR; OTC: BB)
11.06.07
FDA Approves CLIA Waiver for StatSure’s Patented Barrel Technology for Rapid HIV Testing.

StatSure Diagnostic Systems, Inc.
(NASDAQ:SSUR; OTC: BB)
10.25.07
Opportunity Unfolds for Investors Seeking to Participate In Proprietary Point-of-Care Product Firm.

Neurobiological Technologies, Inc.
(NTII: NASDAQ)
09.19.07
The Secret of Success is Constancy of Purpose: VIPRINEX™ Could Restore Stroke Patients to Fuller Lives and They Will Be the Real Miracle of NTII's Achievement.

Arbios Systems, Inc.
(NASDAQ: OTC.BB)
09.13.07
Enhancing the Survival of Patients with Life Threatening Episodes of Liver Failure.

Advanced Research Technologies, Inc.
(ARA.TO: TSX)
08.20.07
Mapping the Road Ahead With an Execution Agenda.

Advanced Research Technologies, Inc.
(ARA.TO: TSX)
05.16.07
The Future and the Products are Now in Their Hands.

Neurobiological Technologies, Inc.
(NTII: NASDAQ)
05.15.07
Clinical Trials Don't Come Cheap Especially When there are Multiple Sites in the US and Internationally.

Advanced Cell Technology, Inc.
(OTC: BB: ACTC)
05.08.07
"Hemangioblast" Precursor Cells Produced From Human Embryonic Stem Cells Show Remarkable Ability to Repair Vascular Damage in Animals.

Arbios Systems, Inc.
(NASDAQ: ABOS: OTC: BB)
04.26.07
SEPET™ Advances Facilitate a Financing with New Institutional Investors.

Advanced Cell Technology, Inc.
(OTC: BB: ACTC)
04.18.07
Translating Stem Cell Development into Therapeutic Outcomes.

Advanced Research Technologies, Inc.
(ARA.TO: TSX)
03.27.07
A CE Marking for the EU and an Unconditional Health Canada Medical Device License to Commercialize SoftScan®, a Financing and an Extension of its Agreement with GE Healthcare for eXplore Optix™

Neurobiological Technologies, Inc.
(NTII: NASDAQ)
02.13.07
Royalties Pour In, Momentum Rebuilds, Losses Decrease and Encouraging Viprinex™ Clinical Trials Advance Supported by the Role of Fibrinogen in Influencing Stroke Outcome.

Advanced Cell Technology, Inc.
(OTC: BB: ACTC)
01.29.07
The Road to Commercial Development of New Therapies from Stem Cells.

Arbios Systems, Inc.
(NASDAQ: ABOS: OTC: BB)
01.17.07
Developing Multiple Products to Meet the Unmet Medical Needs of Patients in Liver Crisis.

<%@ include file="/includes/footer.jsp" %>